Related Experiment Video
Updated: Jan 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Optimizing Perioperative Anticoagulant Management: Balancing Thromboembolic and Bleeding Risks
Khyati Patel1,2, Sean P Kane1,2
1Khyati Patel, PharmD, BCACP, Associate Professor, Ambulatory Care Pharmacist, Department of Pharmacy Practice, College of Pharmacy, Rosalind Franklin University of Medicine and Science, Family Practice Clinic, Advocate Aurora Medical Center, Kenosha, Wisconsin.
Abstract:
Interruption of anticoagulation for a surgical procedure is individualized and based on balancing the risk of perioperative thromboembolism versus the risk of bleeding. Risk assessment for thromboembolism is based on the indication for anticoagulation and a variety of patient-specific factors. Bleeding risk assessment is also largely based on patient factors, such as age and comorbidities, but also the type of procedure being done. The post-operative bleeding risk of surgical procedures can be categorized as high-risk, low-to-moderate-risk, and minimal risk. Each risk category has unique recommendations regarding how long to hold anticoagulation prior to the procedure and when anticoagulation can be safely resumed. Lastly, the type of anticoagulant plays a role in the perioperative strategy based on the duration of action and onset of anticoagulation. Nurses play an important role in risk assessment, patient education, and administration and monitoring of anticoagulants in the perioperative setting.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Peripheral Artery Disease V: Postoperative Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
